Coated transplant and method for making same
AssigneeThe Regents of the University of California
InventorKent C. Cochrum
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorKent C. Cochrum
Estimating the term…
Transplants are coated with an insoluble immunological barrier membrane. The membrane can comprise a non-cytotoxic first layer of agarose and cationic amino acid polymer and a non-cytotoxic second layer chemically bonded to said first layer, the second layer comprising an anionic amino acid polymer. The molecular weight of the anionic amino acid polymer is preferably in the range of 2000 to 500,000 daltons, and the thickness if the total membrane coating is within the range of 1 and 100 microns. Alternatively, the membrane can comprise a non-cytotoxic first layer of a cationic amino acid polymer. A non-cytotoxic second layer chemically bonded to the first layer comprises agarose and an anionic amino acid polymer. A non-cytotoxic optional third layer chemically bonded to said second layer comprises a cationic amino acid polymer. The molecular weight of the cationic acid polymer of the third layer is in the range of from 2,000 to 500,000 daltons and the thickness of the total coating is between 1 and 100 microns. The transplants can be allografts of endocrine cells or tissues such a pancreatic islets. The preferred cationic amino acids are L-lysine, poly-L-arginine, and mixtures thereof, and the preferred anionic amino acids are L-aspartic acid, L-glutamic acid, and mixtures thereof. The coatings are formed by applying corresponding successive solutions to the cells or tissue of the transplant and by forming droplets in immiscible oils.
A method for coating a tissue transplant with an immunological barrier protecting the transplant against destruction by the immune system of an immunologically incompatible transplant host recipient, said method comprising steps:
The method of claim 6 wherein the mixture of step (b) containing the transplant coated with agarose sol is chilled by introducing said mixture into a noncytotoxic, pharmaceutically acceptable oil at a temperature above the agarose gelling temperature and chilling said mixture with continuous stirring to the gelling temperature of the agarose.
A method for coating a tissue transplant with an immunological barrier protecting the transplant against destruction by the immune system of an immunologically incompatible transplant host recipient, said method comprising steps:
Dependencies are inferred from the claim text.